{"id":"https://openalex.org/W2991360855","doi":"https://doi.org/10.1186/s40425-019-0824-5","title":"Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions","display_name":"Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions","alternate_titles":[],"publication_year":2019,"publication_date":"2019-11-29","ids":{"openalex":"https://openalex.org/W2991360855","doi":"https://doi.org/10.1186/s40425-019-0824-5","mag":"2991360855","pmid":"https://pubmed.ncbi.nlm.nih.gov/31783782","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6884868"},"language":"en","primary_location":{"id":"doi:10.1186/s40425-019-0824-5","doi":"https://doi.org/10.1186/s40425-019-0824-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0824-5","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/333.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2991360855"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/7/1/333.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046106054","display_name":"Marc Hilmi","orcid":"https://orcid.org/0000-0003-4762-6740","observed_orcids":["https://orcid.org/0000-0003-4762-6740"]},"institutions":[{"id":"https://openalex.org/I195731000","display_name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","ror":"https://ror.org/03mkjjy25","country_code":"FR","type":"education","lineage":["https://openalex.org/I195731000","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marc Hilmi","raw_affiliation_strings":["Department of Medical Oncology, Curie Institute, University of Versailles Saint-Quentin, Paris, France","0000 0001 2323 0229grid.12832.3aDepartment of Medical Oncology, Curie InstituteUniversity of Versailles Saint-Quentin\nParis\nFrance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Curie Institute, University of Versailles Saint-Quentin, Paris, France","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I80043"]},{"raw_affiliation_string":"0000 0001 2323 0229grid.12832.3aDepartment of Medical Oncology, Curie InstituteUniversity of Versailles Saint-Quentin\nParis\nFrance","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008077511","display_name":"Cindy Neuzillet","orcid":"https://orcid.org/0000-0001-7037-7477","observed_orcids":["https://orcid.org/0000-0001-7037-7477"]},"institutions":[{"id":"https://openalex.org/I195731000","display_name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","ror":"https://ror.org/03mkjjy25","country_code":"FR","type":"education","lineage":["https://openalex.org/I195731000","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cindy Neuzillet","raw_affiliation_strings":["Department of Medical Oncology, Curie Institute, University of Versailles Saint-Quentin, Paris, France","0000 0001 2323 0229grid.12832.3aDepartment of Medical Oncology, Curie InstituteUniversity of Versailles Saint-Quentin\nParis\nFrance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Curie Institute, University of Versailles Saint-Quentin, Paris, France","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I80043"]},{"raw_affiliation_string":"0000 0001 2323 0229grid.12832.3aDepartment of Medical Oncology, Curie InstituteUniversity of Versailles Saint-Quentin\nParis\nFrance","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066134441","display_name":"Julien Cald\u00e9raro","orcid":"https://orcid.org/0000-0002-5370-0807","observed_orcids":["https://orcid.org/0000-0002-5370-0807"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I3019246885","display_name":"Centre Hospitalier Universitaire Henri-Mondor","ror":"https://ror.org/04m61mj84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019246885"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]},{"id":"https://openalex.org/I4210159433","display_name":"Institut Mondor de Recherche Biom\u00e9dicale","ror":"https://ror.org/04qe59j94","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I17606148","https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4210159433"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julien Calderaro","raw_affiliation_strings":["Department of Pathology, Henri Mondor Hospital, Cr\u00e9teil, France","IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","0000 0001 2292 1474grid.412116.1Department of PathologyHenri Mondor Hospital\nCr\u00e9teil\nFrance","0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Henri Mondor Hospital, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0001 2292 1474grid.412116.1Department of PathologyHenri Mondor Hospital\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052451231","display_name":"Fouad Lafdil","orcid":"https://orcid.org/0000-0002-4275-1174","observed_orcids":["https://orcid.org/0000-0002-4275-1174"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I185839726","display_name":"Institut Universitaire de France","ror":"https://ror.org/055khg266","country_code":"FR","type":"education","lineage":["https://openalex.org/I185839726"]},{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I4210159433","display_name":"Institut Mondor de Recherche Biom\u00e9dicale","ror":"https://ror.org/04qe59j94","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I17606148","https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4210159433"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fouad Lafdil","raw_affiliation_strings":["IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","Institut Universitaire de France, Paris, France","Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","0000 0001 1931 4817grid.440891.0Institut Universitaire de France\nParis\nFrance","0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]},{"raw_affiliation_string":"Institut Universitaire de France, Paris, France","institution_ids":["https://openalex.org/I185839726"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0001 1931 4817grid.440891.0Institut Universitaire de France\nParis\nFrance","institution_ids":["https://openalex.org/I185839726"]},{"raw_affiliation_string":"0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051956323","display_name":"Jean\u2013Michel Pawlotsky","orcid":"https://orcid.org/0000-0003-0745-7559","observed_orcids":["https://orcid.org/0000-0003-0745-7559"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I197681013","display_name":"Universit\u00e9 Paris-Est Cr\u00e9teil","ror":"https://ror.org/05ggc9x40","country_code":"FR","type":"education","lineage":["https://openalex.org/I197681013","https://openalex.org/I2800365227"]},{"id":"https://openalex.org/I3019246885","display_name":"Centre Hospitalier Universitaire Henri-Mondor","ror":"https://ror.org/04m61mj84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019246885"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]},{"id":"https://openalex.org/I4210159433","display_name":"Institut Mondor de Recherche Biom\u00e9dicale","ror":"https://ror.org/04qe59j94","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I17606148","https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4210159433"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Michel Pawlotsky","raw_affiliation_strings":["IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Henri Mondor Hospital, Cr\u00e9teil, France","Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","0000 0001 2292 1474grid.412116.1National Reference Center for Viral Hepatitis B, C and D, Department of VirologyHenri Mondor Hospital\nCr\u00e9teil\nFrance","0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMRB-INSERM U955 Team 18, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]},{"raw_affiliation_string":"National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Henri Mondor Hospital, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Est-Cr\u00e9teil, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0001 2149 7878grid.410511.0Universit\u00e9 Paris-Est-Cr\u00e9teil\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I197681013"]},{"raw_affiliation_string":"0000 0001 2292 1474grid.412116.1National Reference Center for Viral Hepatitis B, C and D, Department of VirologyHenri Mondor Hospital\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I3019246885","https://openalex.org/I4210130325"]},{"raw_affiliation_string":"0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016826695","display_name":"Beno\u00eet Rousseau","orcid":"https://orcid.org/0000-0002-1594-4827","observed_orcids":["https://orcid.org/0000-0002-1594-4827"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210159433","display_name":"Institut Mondor de Recherche Biom\u00e9dicale","ror":"https://ror.org/04qe59j94","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I17606148","https://openalex.org/I197681013","https://openalex.org/I2800365227","https://openalex.org/I4210159433"]}],"countries":["FR","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Benoit Rousseau","raw_affiliation_strings":["Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ben.rousseau@gmail.com","IMRB-INSERM U955 Team 18, Cr\u00e9teil, France. ben.rousseau@gmail.com","0000 0001 2171 9952grid.51462.34Department of Medicine, Division of Solid Tumor OncologyMemorial Sloan Kettering Cancer Center\nNew York\nNY\nUSA","0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance"],"raw_orcid":"https://orcid.org/0000-0003-3556-5178","affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. ben.rousseau@gmail.com","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"IMRB-INSERM U955 Team 18, Cr\u00e9teil, France. ben.rousseau@gmail.com","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]},{"raw_affiliation_string":"0000 0001 2171 9952grid.51462.34Department of Medicine, Division of Solid Tumor OncologyMemorial Sloan Kettering Cancer Center\nNew York\nNY\nUSA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"0000 0004 0386 3258grid.462410.5IMRB-INSERM U955 Team 18\nCr\u00e9teil\nFrance","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210159433"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5016826695"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I154526488","https://openalex.org/I4210159433"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":3.2096,"has_fulltext":true,"cited_by_count":180,"citation_normalized_percentile":{"value":0.95416079,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"7","issue":"1","first_page":"333","last_page":"333"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.06480000168085098,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":1.0},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/vegf-a-inhibition","display_name":"VEGF-A inhibition","score":0.777999997138977},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9020000100135803},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8889999985694885},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8460000157356262},{"id":"https://openalex.org/keywords/immune-signatures","display_name":"immune signatures","score":0.6340000033378601},{"id":"https://openalex.org/keywords/tert-mutation","display_name":"TERT mutation","score":0.6759999990463257},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.859000027179718},{"id":"https://openalex.org/keywords/ctnnb1-mutation","display_name":"CTNNB1 mutation","score":0.9470000267028809}],"concepts":[{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.7508575916290283},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6097456812858582},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5982574224472046},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5185154676437378},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.461748868227005},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.41682565212249756},{"id":"https://openalex.org/C148043351","wikidata":"https://www.wikidata.org/wiki/Q4456944","display_name":"Current (fluid)","level":2,"score":0.41205528378486633},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.36317676305770874},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34606075286865234},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3348017930984497},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24130341410636902},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1142437756061554},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004198","descriptor_name":"Disease Susceptibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008113","descriptor_name":"Liver Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D056747","descriptor_name":"Immunomodulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/s40425-019-0824-5","doi":"https://doi.org/10.1186/s40425-019-0824-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0824-5","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/333.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5848286","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6884868","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6884868","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6884868/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Immunother Cancer","raw_type":"Text"},{"id":"pmid:31783782","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31783782","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for immunotherapy of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d5a2e750fdad4bea97d819e3f3abcfab","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/d5a2e750fdad4bea97d819e3f3abcfab","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s40425-019-0824-5","doi":"https://doi.org/10.1186/s40425-019-0824-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40425-019-0824-5","pdf_url":"https://jitc.bmj.com/content/jitc/7/1/333.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal for ImmunoTherapy of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2991360855.pdf","grobid_xml":"https://content.openalex.org/works/W2991360855.grobid-xml"},"referenced_works_count":81,"referenced_works":["https://openalex.org/W1498931318","https://openalex.org/W1757407923","https://openalex.org/W1828082159","https://openalex.org/W1965536826","https://openalex.org/W1969776963","https://openalex.org/W1971837077","https://openalex.org/W1983517349","https://openalex.org/W1985987855","https://openalex.org/W1994193851","https://openalex.org/W2002906231","https://openalex.org/W2009519656","https://openalex.org/W2035747243","https://openalex.org/W2046000826","https://openalex.org/W2051684210","https://openalex.org/W2052151802","https://openalex.org/W2052730188","https://openalex.org/W2053988604","https://openalex.org/W2058887247","https://openalex.org/W2061421862","https://openalex.org/W2064554456","https://openalex.org/W2068149517","https://openalex.org/W2073830661","https://openalex.org/W2092275144","https://openalex.org/W2098087622","https://openalex.org/W2101031676","https://openalex.org/W2101459399","https://openalex.org/W2102942095","https://openalex.org/W2111070218","https://openalex.org/W2114618441","https://openalex.org/W2119242310","https://openalex.org/W2120967735","https://openalex.org/W2128965737","https://openalex.org/W2141444851","https://openalex.org/W2158207366","https://openalex.org/W2158378236","https://openalex.org/W2163486683","https://openalex.org/W2168631000","https://openalex.org/W2221895944","https://openalex.org/W2234453634","https://openalex.org/W2277004004","https://openalex.org/W2286222994","https://openalex.org/W2315690141","https://openalex.org/W2460907708","https://openalex.org/W2495512985","https://openalex.org/W2499029168","https://openalex.org/W2511951051","https://openalex.org/W2528647848","https://openalex.org/W2546700240","https://openalex.org/W2560499218","https://openalex.org/W2563026956","https://openalex.org/W2606367731","https://openalex.org/W2625559053","https://openalex.org/W2626033245","https://openalex.org/W2735683840","https://openalex.org/W2759382352","https://openalex.org/W2772125201","https://openalex.org/W2787358630","https://openalex.org/W2790574591","https://openalex.org/W2796207838","https://openalex.org/W2805592007","https://openalex.org/W2809889937","https://openalex.org/W2883204623","https://openalex.org/W2884137766","https://openalex.org/W2888034354","https://openalex.org/W2890487472","https://openalex.org/W2890595557","https://openalex.org/W2898130255","https://openalex.org/W2899174828","https://openalex.org/W2907564726","https://openalex.org/W2908573150","https://openalex.org/W2911120667","https://openalex.org/W2947072948","https://openalex.org/W2947077957","https://openalex.org/W2947105080","https://openalex.org/W2947829857","https://openalex.org/W3139763557","https://openalex.org/W3145648199","https://openalex.org/W4211105405","https://openalex.org/W4211183069","https://openalex.org/W4242769447","https://openalex.org/W4324262440"],"related_works":["https://openalex.org/W4284993844","https://openalex.org/W4308718296","https://openalex.org/W4281796353","https://openalex.org/W4384616586","https://openalex.org/W4282943420","https://openalex.org/W3215943325","https://openalex.org/W2999298357","https://openalex.org/W3008879337","https://openalex.org/W4410043991","https://openalex.org/W4312140310"],"abstract_inverted_index":{"Hepatocellular":[0],"carcinoma":[1],"(HCC)":[2],"is":[3],"the":[4,29,104,113,188,202,214,226],"second":[5],"deadliest":[6],"cancer":[7],"worldwide,":[8],"due":[9],"to":[10,102,109,200,241,247,262],"its":[11,70],"high":[12,71],"incidence":[13],"and":[14,56,73,76,108,111,124,139,145,190,194,225,238,242,250,260],"poor":[15],"prognosis.":[16],"Frequent":[17],"initial":[18],"presentation":[19],"at":[20],"advanced":[21],"stages":[22],"along":[23],"with":[24,38,174,182,253],"impaired":[25],"liver":[26],"function":[27],"limit":[28],"use":[30],"of":[31,98,116,141,169,187,204,213,217,220],"a":[32,153],"broad":[33],"therapeutic":[34,59,84,206],"arsenal":[35],"in":[36,48,90,152,180,223],"patients":[37,181],"HCC.":[39,91,183],"Although":[40],"main":[41],"HCC":[42,94,224],"oncogenic":[43],"drivers":[44],"have":[45,87],"been":[46],"deciphered":[47],"recent":[49],"years":[50],"(TERT,":[51],"TP53,":[52],"CTNNB1":[53],"mutations,":[54],"miR122":[55],"CDKN2A":[57],"silencing),":[58],"applications":[60],"derived":[61],"from":[62,164],"this":[63],"molecular":[64],"knowledge":[65],"are":[66,82,172],"still":[67],"limited.":[68],"Given":[69],"vascularization":[72],"immunogenicity,":[74],"antiangiogenics":[75,123],"immune":[77,95,106,156,196,251],"checkpoint":[78],"inhibitors":[79],"(ICI),":[80],"respectively,":[81],"two":[83],"approaches":[85],"that":[86],"shown":[88],"efficacy":[89],"Depending":[92],"on":[93,235],"profile,":[96],"combinations":[97,168],"these":[99,170],"therapies":[100,121,171,222],"aim":[101],"modify":[103],"protumoral/antitumoral":[105],"balance,":[107],"reactivate":[110],"favor":[112],"intratumoral":[114,137],"trafficking":[115],"cytotoxic":[117,142],"T":[118,143,148],"cells.":[119],"Combination":[120],"involving":[122],"ICI":[125,159],"may":[126],"be":[127],"synergistic,":[128],"because":[129],"vascular":[130],"endothelial":[131],"growth":[132],"factor":[133],"A":[134,184],"inhibition":[135],"increases":[136],"infiltration":[138],"survival":[140],"lymphocytes":[144],"decreases":[146],"regulatory":[147],"lymphocyte":[149],"recruitment,":[150],"resulting":[151],"more":[154],"favorable":[155],"microenvironment":[157],"for":[158,229,256],"antitumoral":[160,195,221],"activity.":[161],"First":[162],"results":[163],"clinical":[165,218,258],"trials":[166],"evaluating":[167],"encouraging":[173],"response":[175,261],"rates":[176],"never":[177],"observed":[178],"before":[179],"better":[185],"understanding":[186],"balance":[189],"interactions":[191],"between":[192],"protumoral":[193],"cells":[197],"will":[198,245],"help":[199,246],"ensure":[201],"success":[203],"future":[205],"trials.":[207],"Here,":[208],"we":[209],"present":[210],"an":[211],"overview":[212],"current":[215],"state":[216],"development":[219],"biological":[227],"rationale":[228],"their":[230],"use.":[231],"Moreover,":[232],"translational":[233],"studies":[234],"tumor":[236],"tissue":[237],"blood,":[239],"prior":[240],"during":[243],"treatment,":[244],"identify":[248],"biomarkers":[249],"signatures":[252],"predictive":[254],"value":[255],"both":[257],"outcome":[259],"combination":[263],"therapies.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2991360855","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":48},{"year":2021,"cited_by_count":37},{"year":2020,"cited_by_count":34}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2019-12-05T00:00:00"}
